BFM
BEAT

Boothbay Fund Management’s BioTelemetry, Inc. BEAT Stock Holding History

Boothbay Fund Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-23,068
Closed -$1.05M – 1611
2020
Q3 		$1.05M Buy
+23,068
New +$964K 0.06% 407

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Boothbay Fund Management's BEAT Position: Q4 2020 in Review

Boothbay Fund Management sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 23,068 shares — an estimated $1.05M sold.

Boothbay Fund Management first reported a position in BEAT in Q3 2020 and held it in 1 quarter. The position peaked at $1.05M in Q3 2020. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

  • Boothbay Fund Management reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
  • Boothbay Fund Management sold 23,068 BioTelemetry, Inc. shares in Q4 2020, an estimated $1.05M.
  • Boothbay Fund Management first reported a position in BioTelemetry, Inc. in Q3 2020 and held it in 1 quarter.
  • Boothbay Fund Management's BioTelemetry, Inc. position peaked at $1.05M in Q3 2020.
  • 238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on Boothbay Fund Management's 13F filing for Q4 2020, filed 12 Feb 2021.